| |
| |
|
| Insider
Information: |
Frates James M |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
318,827 |
|
|
Indirect Shares
|
184,010 |
|
|
| Direct
Value |
$2,148,775 |
|
|
|
Indirect Value
|
$3,642,655 |
|
|
| Total
Shares |
502,837 |
|
|
| Total
Value |
$5,791,430 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alkermes Plc |
ALKS |
SVP, Alks Inc; CFO ALKS |
2020-05-14 |
91,828 |
2020-05-14 |
155,669 |
Premium* |
|
|
Sage Therapeutics, Inc. |
SAGE |
|
2021-06-16 |
1,035 |
2021-06-16 |
1,810 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-04-16 |
225,964 |
2024-04-16 |
26,531 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
262 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2013-02-14 |
4 |
AS |
$21.34 |
$186,754 |
D/D |
(8,750) |
92,207 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2013-02-14 |
4 |
OE |
$9.97 |
$87,238 |
D/D |
8,750 |
100,957 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• – – |
2012-02-01 |
4 |
OE |
$7.36 |
$73,600 |
D/D |
10,000 |
89,625 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• – – |
2012-02-01 |
4 |
AS |
$18.97 |
$189,687 |
D/D |
(10,000) |
79,625 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-01-15 |
4 |
OE |
$9.21 |
$92,100 |
D/D |
10,000 |
87,162 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-01-15 |
4 |
AS |
$66.55 |
$668,624 |
D/D |
(10,000) |
77,162 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-02-03 |
4 |
OE |
$9.21 |
$92,100 |
D/D |
10,000 |
87,162 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-02-03 |
4 |
AS |
$70.39 |
$708,306 |
D/D |
(10,000) |
77,162 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-03-10 |
4 |
AS |
$66.15 |
$662,496 |
D/D |
(10,000) |
78,649 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-03-10 |
4 |
OE |
$9.21 |
$92,100 |
D/D |
10,000 |
88,649 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-04-15 |
4 |
AS |
$62.42 |
$624,218 |
D/D |
(10,000) |
78,649 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-04-15 |
4 |
OE |
$9.21 |
$92,100 |
D/D |
10,000 |
88,649 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-05-12 |
4 |
OE |
$11.74 |
$117,400 |
D/D |
10,000 |
88,649 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-05-12 |
4 |
AS |
$59.34 |
$593,423 |
D/D |
(10,000) |
78,649 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-06-16 |
4 |
OE |
$11.74 |
$117,400 |
D/D |
10,000 |
58,713 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-06-16 |
4 |
AS |
$58.63 |
$586,349 |
D/D |
(10,000) |
48,713 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-08-11 |
4 |
AS |
$67.63 |
$679,747 |
D/D |
(10,000) |
48,713 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-08-11 |
4 |
OE |
$14.38 |
$143,800 |
D/D |
10,000 |
58,713 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-11-10 |
4 |
AS |
$72.34 |
$723,395 |
D/D |
(10,000) |
49,857 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-11-10 |
4 |
OE |
$15.95 |
$159,500 |
D/D |
10,000 |
59,857 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-21 |
4 |
OE |
$0.00 |
$104,300 |
D/D |
10,750 |
44,673 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-10-31 |
4 |
GA |
$0.00 |
$0 |
I/I |
11,072 |
11,072 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-10-31 |
4 |
D |
$50.55 |
$599,927 |
D/D |
(11,868) |
77,162 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-11-07 |
4 |
AS |
$49.98 |
$664,944 |
D/D |
(13,303) |
77,162 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-11-07 |
4 |
OE |
$8.55 |
$164,541 |
D/D |
13,303 |
90,465 |
0 |
- |
|
262 Records found
|
|
Page 8 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
